Clinical TrialsSearch results
Number of results: 660
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Antiremodeling effect of leukotriene receptor antagonist (pranlukast) in asthmatic subjects with chronic airflow limitation as assessed with computed tomography (CT).
- asthma
- Kyoto University Hospitaly
- 2007-08-10
Other
- A randomized phase II/III study of ACNU versus Procarbazine plus ACNU as a postoperative chemoradiotherapy for strocytoma grade 3 and 4(JCOG0305, ACNU+PCZ PhaseII/III)
- astrocytoma grade 3/4
- Japan Clinical Oncology Group(JCOG)
- 2005-09-02
Recruiting
- Double-blind, randomized, controlled trial of EIM-001 for in patients with Fontaine classification 3 and 4 lower extremity atherosclerosis obliterans
- atherosclerosis obliterans
- Kato Takao
- 2023-08-25
Recruiting
- Double-blind, randomized, controlled trial of EIM-001 for in patients with Fontaine classification IIb lower extremity atherosclerosis obliterans
- atherosclerosis obliterans
- Takao Kato
- 2023-02-28
Other
- A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab Monotherapy in Moderate-to-severe AD
- Atopic Dermatitis
- Chen Sarah
- 2023-04-03
Completed
- Exploratory analyses of biomarkers in blood and stratum corneum in patients with atopic dermatitis
- Atopic dermatitis
- Tamagawa-Mineoka Risa
- 2022-02-11
Other
- Physician-initiated clinical trial in patients with 5-aminolevulinic acid-induced ATR-X syndrome.
- ATR-X syndrome
- Wada Takahito
- 2022-07-14
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- Study to validate the accuracy of the application to diagnosis the arrhythmia
- Atrial Fibrillation
- Ono Koh
- 2022-11-17
Other
- The Randomized Controlled Trial Evaluating Utility of Catheter Ablation Us ing ExTRa mapping for Atrial Fibrillation
- Atrial fibrillation
- Shizuta Satoshi
- 2021-05-17